Hannes Hagström (Hannes Hagstrom)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 120

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Gut

Alimentary pharmacology & therapeutics

Hepatology communications

Karolinska Institutet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet Sep 15 2019

Sweden

Associate professor, MD PhD :: Department of Medicine, Huddinge

Karolinska University Hospital Sep 15 2016

Sweden

Consultant Hepatologist :: Division of Hepatology, Department of Upper GI

Publications

Rocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, Dorean Nabukalu, Zangin Zeebari, Gaetano Marrone, Bruna Gigante, Larry W Chang, Steven J Reynolds, Fred Nalugoda, Anna Mia Ekström, Hannes Hagström, Helena Nordenstedt
Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey. Alimentary pharmacology & therapeutics 59 (9) (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Hannes Hagström, Hannes Hegmar, Christophe Moreno
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease. United European gastroenterology journal (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Rocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, Dorean Nabukalu, Zangin Zeebari, Gaetano Marrone, Bruna Gigante, Larry W Chang, Steven J Reynolds, Fred Nalugoda, Anna Mia Ekström, Hannes Hagström, Helena Nordenstedt
Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey. Alimentary pharmacology & therapeutics (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut 73 (5) (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Ying Shang, Camilla Akbari, Maja Dodd, Patrik Nasr, Johan Vessby, Fredrik Rorsman, Stergios Kechagias, Per Stål, Mattias Ekstedt, Hannes Hagström
Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD. Gut (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Axel Wester, Prof Peter Jepsen, Hannes Hagström
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut 73 (5) (2024)
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut 73 (5) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Hannes Hagström, Hannes Hegmar, Christophe Moreno
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease. United European gastroenterology journal 12 (2) (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Hanne Åström, Ying Shang, Hannes Hagström, Axel Wester
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression. Liver international : official journal of the International Association for the Study of the Liver (2024)
Xiao-Dong Zhou, Seung-Up Kim, Terry Cheuk Fung Yip, Salvatore Petta, Atsushi Nakajima, Emmanuel Tsochatzis, Jérôme Boursier, Elisabetta Bugianesi, Hannes Hagström, Wah-Kheong Chan, Manuel Romero, Jose Luis Calleja, Victor de Lédinghen, Laurent Castéra, Arun J Sanyal, George Boon-Bee Goh, Philip Noel Newsome, Jiangao Fan, Michelle Lai, Céline Fournier-Poizat, Hye-Won Lee, Grace Lai-Hung Wong, Angelo Armandi, Ying Shang, Grazia Pennisi, Elba Llop, Masato Yoneda, Marc de Saint-Loup, Clémence M Canivet, Carmen Lara-Romero, Rocio Gallego-Duràn, Amon Asgharpour, Kevin Kim-Jun Teh, Sara Mahgoub, Mandy Sau-Wai Chan, Huapeng Lin, Wen-Yue Liu, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Ming-Hua Zheng, null null
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. Gut (2024)
Ferenc Emil Mózes, Jenny A Lee, Yasaman Vali, Emmanuel A Selvaraj, Arjun N A Jayaswal, Jérôme Boursier, Victor De Ledinghen, Monica Lupsor-Platon, Yusuf Yilmaz, Wah-Kheong Chan, Sanjiv Mahadeva, Thomas Karlas, Johannes Wiegand, null Shalimar, Emmanuel A Tsochatzis, Antonio Liguori, Vincent Wai-Sun Wong, Dae Ho Lee, Adriaan Georgius Holleboom, Anne-Marieke Van Dijk, Anne Linde Mak, Hannes Hagström, Camilla Akbari, Masashi Hirooka, Dong Hyeon Lee, Won Kim, Takeshi Okanoue, Toshihide Shima, Hirokazu Takahashi, Masato Yoneda, Paul J Thuluvath, Feng Li, Annalisa Berzigotti, Yuly P Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier-Poizat, Andreas Geier, Theresa Tuthill, Carla Yunis, Quentin M Anstee, Stephen A Harrison, Patrick M Bossuyt, Michael Pavlides
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Hannes Hagström, Hannes Hegmar, Christophe Moreno
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease. United European gastroenterology journal 12 (2) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Hannes Hagström, Hannes Hegmar, Christophe Moreno
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease. United European gastroenterology journal 12 (2) (2024)
Rocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, Dorean Nabukalu, Zangin Zeebari, Gaetano Marrone, Bruna Gigante, Larry W Chang, Steven J Reynolds, Fred Nalugoda, Anna Mia Ekström, Hannes Hagström, Helena Nordenstedt
Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey. Alimentary pharmacology & therapeutics 59 (9) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut 73 (5) (2024)
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients. Liver international : official journal of the International Association for the Study of the Liver 44 (7) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut (2024)
Hannes Hegmar, Axel Wester, Soo Aleman, Jens Backman, Erik Degerman, Håkan Ekvall, Katarina Lund, Åsa Lundgren, Patrik Nasr, Afshin Shahnavaz, Johan Vessby, Johan Westin, Kristina Önnerhag, Hannes Hagström
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut 73 (5) (2024)
Patrik Nasr, Ying Shang, Axel Wester, Rickard Strandberg, Linnea Widman, Jeffrey Victor Lazarus, Hannes Hagström
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease. Liver international : official journal of the International Association for the Study of the Liver (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Olivier Govaere, Antonio Liguori, Paolo Francione, Rocìo Gallego-Duràn, Javier Ampuero, Grazia Pennisi, Rocio Aller, Dina Tiniakos, Alastair Burt, Ezio David, Fabio Vecchio, Marco Maggioni, Daniela Cabibi, Duncan McLeod, Maria Jesus Pareja, Marco Y W Zaki, Antonio Grieco, Per Stål, Stergios Kechagias, Anna Ludovica Fracanzani, Luca Vittorio Valenti, Luca Miele, Piero Fariselli, Mohammed Eslam, Salvatore Petta, Hannes Hagström, Jacob George, Jörn M Schattenberg, Manuel Romero, Quentin Mark Anstee, Elisabetta Bugianesi
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease. Gut (2024)
Hannes Hegmar, Thomas Wiggers, Patrik Nasr, Johan Vessby, Stergios Kechagias, Nils Nyhlin, Hanns-Ulrich Marschall, Åsa Danielsson Borssén, Rickard Strandberg, Morten Karsdal, Diana Julie Leeming, Mattias Ekstedt, Hannes Hagström
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD. Journal of internal medicine (2024)
Axel Wester, Prof Peter Jepsen, Hannes Hagström
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Hannes Hegmar, Thomas Wiggers, Patrik Nasr, Johan Vessby, Stergios Kechagias, Nils Nyhlin, Hanns-Ulrich Marschall, Åsa Danielsson Borssén, Rickard Strandberg, Morten Karsdal, Diana Julie Leeming, Mattias Ekstedt, Hannes Hagström
Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD. Journal of internal medicine 296 (2) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut 73 (5) (2024)
Rocio Enriquez, Mahmoud Homsi, Robert Ssekubugu, Dorean Nabukalu, Zangin Zeebari, Gaetano Marrone, Bruna Gigante, Larry W Chang, Steven J Reynolds, Fred Nalugoda, Anna Mia Ekström, Hannes Hagström, Helena Nordenstedt
Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey. Alimentary pharmacology & therapeutics 59 (9) (2024)
Hannes Hagström, Hannes Hegmar, Christophe Moreno
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease. United European gastroenterology journal 12 (2) (2024)
Wen Yang, Fahim Ebrahimi, Stefano Romeo, Magnus Holmer, Johan Vessby, Mattias Ekstedt, Jonas F Ludvigsson, Ying Shang, Hannes Hagström
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Axel Wester, Ying Shang, Emilie Toresson Grip, Anthony A Matthews, Hannes Hagström
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes. Gut (2024)
Fahim Ebrahimi, Tracey G Simon, Hannes Hagström, Jiangwei Sun, David Bergman, Anders Forss, Bjorn Roelstraete, Lars Engstrand, Jonas F Ludvigsson
Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Ying Shang, Linnea Widman, Fahim Ebrahimi, Jonas F Ludvigsson, Hannes Hagström, Axel Wester
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Hannes Hagström, Niklas Hammar
Editorial: moving from the clinic towards population hepatology-authors' reply. Alimentary pharmacology & therapeutics 57 (6) (2023)
Johanna Schönau, Axel Wester, Hannes Hagström, Jörn Markus Schattenberg
Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis. Journal of internal medicine (2023)
Hannes Hagström, Jonas F Ludvigsson
Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children. Alimentary pharmacology & therapeutics 57 (6) (2023)
Hanne Åström, Axel Wester, Hannes Hagström
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients. Scandinavian journal of gastroenterology (2023)
Hannes Hagström, Tracey G Simon, Jonas Söderling, Jonas F Ludvigsson
Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates. Hepatology communications 7 (2) (2023)
Patrik Nasr, Erik von Seth, Raphaela Mayerhofer, Nelson Ndegwa, Jonas F Ludvigsson, Hannes Hagström
Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019. European journal of epidemiology (2023)
Hannes Hagström, Tracey G Simon, Jonas Söderling, Jonas F Ludvigsson
Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates. Hepatology communications 7 (2) (2023)
Axel Wester, Ying Shang, Per Stål, Hannes Hagström
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study. Hepatology communications 7 (10) (2023)
Fredrik O Åberg, Ying Shang, Rickard Strandberg, Axel Wester, Linnea Widman, Hannes Hagström
Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients. United European gastroenterology journal (2023)
Mark D Theodoreson, Guruprasad Padur Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Denis Moir, Richard Parker
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Mark D Theodoreson, Guruprasad Padur Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Denis Moir, Richard Parker
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Fredrik O Åberg, Hannes Hagström
Challenges with neuropsychiatric Wilson's disease. United European gastroenterology journal (2023)
Johanna Schönau, Axel Wester, Jörn Markus Schattenberg, Hannes Hagström
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study. Journal of internal medicine (2023)
Mark D Theodoreson, Guruprasad Padur Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Denis Moir, Richard Parker
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis. Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Johanna Schönau, Axel Wester, Jörn Markus Schattenberg, Hannes Hagström
Risk of fractures and post-fracture mortality in 3,980 people with Primary Biliary Cholangitis: A population-based cohort study. Journal of internal medicine (2023)
Hannes Hagström, Tracey G Simon, Jonas Söderling, Jonas F Ludvigsson
Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates. Hepatology communications 7 (2) (2023)
Mark D Theodoreson, Guruprasad Padur Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Denis Moir, Richard Parker
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Mark D Theodoreson, Guruprasad Padur Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Hannes Hagström, Stine Johansen, Aleksander Krag, Alisa Likhitsup, Steven Masson, Anne McCune, Neil Rajoriya, Maja Thiele, Denis Moir, Richard Parker
Extra-hepatic Morbidity and Mortality in Alcohol-related Liver Disease: Systematic Review and Meta-analysis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Jacinth Yan, Hannes Hagström, Eliane Sardh, Staffan Wahlin
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals. Journal of inherited metabolic disease 46 (2) (2022)
Ana Dugic, Hannes Hagström, Ingrid A Dahlman, Wiktor Rutkowski, Diana Daou, Paula Kulinski, Johannes Matthias Löhr, Miroslav Vujasinovic
Post-pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes. United European gastroenterology journal (2022)
Ying Shang, Patrik Nasr, Linnea Widman, Hannes Hagström
Risk of cardiovascular disease and loss in life expectancy in NAFLD. Hepatology (Baltimore, Md.) 76 (5) (2022)
Hannes Hagström, Maja Sofie Thiele, Tracey G Simon, Rajani Sharma, Anna Röckert Tjernberg, Bjorn Roelstraete, Jonas Söderling, Jonas F Ludvigsson
Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease. United European gastroenterology journal 10 (2) (2022)
Hannes Hagström, Ying Shang, Axel Wester, Linnea Widman
Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER). Scandinavian journal of gastroenterology 57 (8) (2022)
Sami Qadri, Noora Ahlholm, Ida Lønsmann, Paola Pellegrini, Anni Poikola, Panu K Luukkonen, Kimmo Porthan, Anne Juuti, Henna Sammalkorpi, Anne K Penttilä, Roberta D'Ambrosio, Giorgio Soardo, Diana Julie Leeming, Morten Asser Karsdal, Johanna T Arola, Stergios Kechagias, Serena Pelusi, Mattias Ekstedt, Luca Vittorio Valenti, Hannes Hagström, Hannele Yki-Järvinen
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease. The Journal of clinical endocrinology and metabolism 107 (5) (2022)
Hannes Hagström, Jacinth Yan, Mats Talbäck, Anna Andreasson, Göran Walldius, Matteo Bottai, Niklas Hammar
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers. Alimentary pharmacology & therapeutics 57 (4) (2022)
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Jacinth Yan, Hannes Hagström, Eliane Sardh, Staffan Wahlin
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals. Journal of inherited metabolic disease 46 (2) (2022)
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut (2022)
Hannes Hagström, Magnus Simrén, Anders Ekbom
In memoriam: Rolf Hultcrantz (1949-2022). United European gastroenterology journal 10 (8) (2022)
Hannes Hagström, Jacinth Yan, Mats Talbäck, Anna Andreasson, Göran Walldius, Matteo Bottai, Niklas Hammar
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers. Alimentary pharmacology & therapeutics 57 (4) (2022)
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut 72 (3) (2022)
Axel Wester, Hannes Hagström
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study. Journal of internal medicine 292 (3) (2022)
Sanna Norén, Bonnie Bengtsson, Hannes Hagström, Gunnar Ljunggren, Staffan Wahlin
Hepatocellular carcinoma in Stockholm, Sweden 2003-2018: a population-based cohort study. Scandinavian journal of gastroenterology 57 (9) (2022)
Hannes Hagström, Jacinth Yan, Mats Talbäck, Anna Andreasson, Göran Walldius, Matteo Bottai, Niklas Hammar
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers. Alimentary pharmacology & therapeutics 57 (4) (2022)
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Jacinth Yan, Hannes Hagström, Eliane Sardh, Staffan Wahlin
Risk for incident comorbidities, non-hepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1,244 individuals. Journal of inherited metabolic disease (2022)
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut 72 (3) (2022)
Karl Björkström, Linnea Widman, Hannes Hagström
Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study. Liver international : official journal of the International Association for the Study of the Liver 42 (4) (2022)
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Jacinth Yan, Hannes Hagström, Eliane Sardh, Staffan Wahlin
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals. Journal of inherited metabolic disease 46 (2) (2022)
Magnus Holmer, Mattias Ekstedt, Patrik Nasr, Robin Zenlander, Axel Wester, Federica Tavaglione, Stefano Romeo, Stergios Kechagias, Per Stål, Hannes Hagström
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Hannes Hagström
A new model for estimation of significant fibrosis in primary care. SAFE to use? Hepatology (Baltimore, Md.) (2022)
Juan Vaz, Ulf Strömberg, Patrik Midlöv, Berne Eriksson, David Buchebner, Hannes Hagström
Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients. Journal of internal medicine (2022)
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Matteo Bottai, Marianna Kotopouli, Hannes Hagström, Eliane Sardh, Staffan Wahlin
Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals. Journal of internal medicine 291 (6) (2022)
Hannes Hagström, Ying Shang
Less is more? Screening for steatosis in older populations. Hepatology (Baltimore, Md.) (2022)
Mattias Lissing, Daphne Vassiliou, Ylva Floderus, Pauline Harper, Jacinth Yan, Hannes Hagström, Eliane Sardh, Staffan Wahlin
Risk for incident comorbidities, nonhepatic cancer and mortality in acute hepatic porphyria: A matched cohort study in 1244 individuals. Journal of inherited metabolic disease (2022)
Tracey G Simon, Bjorn Roelstraete, Naim Alkhouri, Hannes Hagström, Johan Sundström, Jonas F Ludvigsson
Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut 72 (3) (2022)
Hannes Hagström, Jacinth Yan, Mats Talbäck, Anna Andreasson, Göran Walldius, Matteo Bottai, Niklas Hammar
Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers. Alimentary pharmacology & therapeutics (2022)
Bonnie Bengtsson, Linnea Widman, Staffan Wahlin, Per Stål, Niklas K Björkström, Hannes Hagström
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study. United European gastroenterology journal 10 (5) (2022)
Ying Shang, Linnea Widman, Hannes Hagström
Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study. Neurology 99 (6) (2022)
Jeffrey Victor Lazarus, Henry E Mark, Massimo G Colombo, Alessandro Rhyl Demaio, John F Dillon, Jacob George, Hannes Hagström, Samantha L Hocking, Nancy Lee, Mark J Nieuwenhuijsen, Mary E Rinella, Manuel Romero, Joan B Soriano, Jörn Markus Schattenberg, Frank Tacke, Emmanuel A Tsochatzis, Luca Vittorio Valenti, Shira Zelber-Sagi, M Ashworth Dirac, Terry T K Huang
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. Alimentary pharmacology & therapeutics (2021)
Hannes Hagström, Nelson Ndegwa, Molly Jalmeus, Mattias Ekstedt, Iris Posserud, Fredrik Rorsman, Nils Nyhlin, Daniel Klintman, Mårten Werner, Hanns-Ulrich Marschall, Johan Askling, Per Stål, null null
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2021)
Hannes Hagström, Dawei Bu, Patrik Nasr, Mattias Ekstedt, Hannes Hegmar, Stergios Kechagias, Ningyan Zhang, Zhiqiang An, Per Stål, Philipp E Scherer
Serum levels of endotrophin are associated with nonalcoholic steatohepatitis. Scandinavian journal of gastroenterology 56 (4) (2021)
Fredrik O Åberg, Christopher J Danford, Maja Thiele, Mats Talbäck, Ditlev Nytoft Rasmussen, Zhenghui Gordon Jiang, Niklas Hammar, Patrik Nasr, Mattias Ekstedt, Anna But, Pauli Puukka, Aleksander Krag, Jouko Sundvall, Iris Erlund, Veikko Salomaa, Per Stål, Stergios Kechagias, Rolf Hultcrantz, Michelle Lai, Nezam Afdhal, Antti Jula, Satu Männistö, Annamari Lundqvist, Markus Perola, Martti Färkkilä, Hannes Hagström
A Dynamic Aspartate-to-Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease. Hepatology communications 5 (6) (2021)

Hannes Hagström.css-eqlu8i{font-size:small;padding-left:4px;} (Hannes Hagstrom)

Publication Activity (10 Years)

Top Topics

Top Venues

Hannes Hagström (Hannes Hagstrom)